Hem
Motgiftet Naloxon, som kan häva dödliga överdoser hos narkotikamissbrukare. (Claudio Bresciani/TT)

Oklart hur fler kan få tillgång till naloxonsprej

Socialstyrelsen håller på att färdigställa en rapport om hur nässprayen naloxon, ett motgift mot opioidöverdoser, ska kunna användas av fler i Sverige, skriver TT. Den 31 mars ska rapporten överlämnas till regeringen.

Det råder ingen tvekan om att naloxon räddar liv, men Läkemedelsverket har redan i en delrapport i Socialstyrelsen avslagit möjligheten att med nuvarande lagstiftning göra nässprejen receptfri.

I dagsläget får naloxon bara skrivas ut till personer som själva riskerar att ta en överdos, men oftast är det snarare personer runt omkring som behöver kunna använda nässprejen. Till exempel har det argumenterats för att vissa yrkesgrupper, som polis och väktare, ska ha tillgång till motgiftet. Men ingen lösning har nåtts – trots efterfrågan från vård och myndigheter.

bakgrund
 
Naloxon
Wikipedia (en)
Naloxone, sold under the brand name Narcan among others, is a medication used to reverse or reduce the effects of opioids. It is commonly used to counter decreased breathing in opioid overdose. Effects begin within two minutes when given intravenously, and within five minutes when injected into a muscle. The medicine can also be administered by spraying it into a person's nose. Naloxone commonly blocks the effects of opioids for 30 to 90 minutes. Multiple doses may be required, as the duration of action of some opioids is greater than that of naloxone. Emergency medical services data from Massachusetts found that 93.5% of people given naloxone survived their overdose.Administration to opioid-dependent individuals may cause symptoms of opioid withdrawal, including restlessness, agitation, nausea, vomiting, a fast heart rate, and sweating. To prevent this, small doses every few minutes can be given until the desired effect is reached. In those with previous heart disease or taking medications that negatively affect the heart, further heart problems have occurred. It appears to be safe in pregnancy, after having been given to a limited number of women. Naloxone is a non-selective and competitive opioid receptor antagonist. It works by reversing the depression of the central nervous system and respiratory system caused by opioids.Naloxone was patented in 1961 and approved for opioid overdose in the United States in 1971. It is on the World Health Organization's List of Essential Medicines. Naloxone is available as a generic medication. In April 2021, the U.S. Food and Drug Administration (FDA) approved a higher dose naloxone hydrochloride nasal spray product (Kloxxado) intended to treat opioid overdose from fentanyl and its analogues, which are many times stronger than heroin.
Omni är politiskt obundna och oberoende. Vi strävar efter att ge fler perspektiv på nyheterna. Har du frågor eller synpunkter kring vår rapportering? Kontakta redaktionen